LivaNova Company
Cardiovascular and neuromodulation through nerve stimulation, e.g. in drug-resistant epilepsy, cardiopulmonary diseases.
Technology:
AgeTech Companies
Industry:
Healthcare
Headquarters:
United Kingdom
Founded Date:
01 01 87
Employees Number:
1001-5000
Funding Status:
IPO
Acquisitions Number:
4
Estimated Revenue:
$100M to $500M
Register and Claim Ownership